Article
AstraZeneca cancer drug Enhertu show encouraging initial results for other tumours
Rating:
0.0
Views:
48
Likes:
1
Library:
1
AstraZeneca said on Monday a mid-stage trial of its cancer drug Enhertu, co-developed with Daiichi Sankyo , showed positive results across multiple HER2-expressing advanced solid tumours in heavily pre-treated patients.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value